Lupin LimitedNSE: LUPIN

Press Release Mar 20 2023

· Issued by Lupin Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-20-2023-1

Lupin Limited has informed the Exchange regarding a press release dated March 20, 2023, titled "Lupin s Alliance Partner Caplin Receives U.S. FDA Approval for Rocuronium BromideInjection.".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases